ClinicalTrials.Veeva

Menu

Lavender During Intrauterine Insemination

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Anxiety
Infertility, Female

Treatments

Other: Water
Other: Lavender

Study type

Interventional

Funder types

Other

Identifiers

NCT03461055
17-001147

Details and patient eligibility

About

The Researchers hope to learn if by using lavender aromatherapy during an intrauterine insemination patients have decreased anxiety and pain at the time of the procedure.

Full description

Infertility patients have a high level of anxiety before and during infertility treatments due to anticipated discomfort of a procedure and anticipation of a long awaited pregnancy. Aromatherapy with lavender, an essential oil, has been shown to be effective in reducing anxiety and pain in a variety of procedures such as Botox injections, cesarean delivery and intrauterine device placement.

Enrollment

62 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women undergoing intrauterine insemination
  • English speaking

Exclusion criteria

  • Allergy to lavender oil or its components
  • Currently using aromatherapy
  • Contraindication to intrauterine insemination
  • Contraindication to pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

62 participants in 2 patient groups, including a placebo group

Lavender
Experimental group
Description:
Lavandula angustifolia aromatherapy. 1 drop on a cotton ball placed in a porous pouch. Given to patients at the time of their intrauterine insemination.
Treatment:
Other: Lavender
Water
Placebo Comparator group
Description:
1 drop of water on a cotton ball placed in a porous pouch. Given to patients at the time of their intrauterine insemination.
Treatment:
Other: Water

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems